The stock market has gone through a correction to begin 2018, and healthcare giant Johnson & Johnson (NYSE: JNJ) has been particularly susceptible to the market's declines. (fool.com)
June's work was funded by healthcare giant Novartis, one of several companies developing the technology. (newscientist.com)
I, on the other hand, reach the conclusion that certain sectors of the economy are rarely prone to failure — conglomerates like 3M and Berkshire Hathaway, water utilities like Aqua America, electric utilities like The Southern Company, diversified healthcare giants like Johnson & Johnson, consumer staples like Coca - Cola and PepsiCo, housecare companies like Colgate - Palmolive and Clorox, and energy supergiants like Exxon and Chevron, all have a very low individual chance of failure. (theconservativeincomeinvestor.com)